Pacific Biosciences of California, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Pacific Biosciences of California, Inc. now
Current reporting with the operating signal separated from the noise.
Transcript : Pacific Biosciences of California, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 04:50 PM
The story matters when it changes Pacific Biosciences of California, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Pacific Biosciences of California, Inc. (PACB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
The story matters when it changes Pacific Biosciences of California, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Is Pacific Biosciences of California, Inc. (PACB) One of the Best Genomics Stocks to Buy According to Wall Street?
Investors are testing whether Pacific Biosciences of California, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Barclays analyst is bullish on Pacific Biosciences of California, Inc. (PACB)
The story matters when it changes Pacific Biosciences of California, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Investors are testing whether Pacific Biosciences of California, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Pacific Biosciences of California, Inc. (PACB) Q3 2025 Earnings Call Transcript
Investors are testing whether Pacific Biosciences of California, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest PACB filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Pacific Biosciences of California, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →